[HTML][HTML] Remdesivir for the treatment of Covid-19

…, S Pett, JD Neaton, TH Burgess… - … England Journal of …, 2020 - Mass Medical Soc
Background Although several therapeutic agents have been evaluated for the treatment of
coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …

Remdesivir for the treatment of Covid-19—preliminary report

…, S Pett, JD Neaton, TH Burgess… - … England Journal of …, 2020 - discovery.ucl.ac.uk
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment
of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …

[HTML][HTML] Baricitinib plus remdesivir for hospitalized adults with Covid-19

…, MC Elie, RT Davey, TH Burgess… - … England Journal of …, 2021 - Mass Medical Soc
Background Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated
inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, …

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

B Tassaneetrithep, TH Burgess… - The Journal of …, 2003 - rupress.org
Dengue virus is a single-stranded, enveloped RNA virus that productively infects human
dendritic cells (DCs) primarily at the immature stage of their differentiation. We now find that all …

SARS-CoV-2 BA. 1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies

…, KJ Erlandson, ED Laing, TH Burgess… - Science Translational …, 2022 - science.org
The rapid spread of the highly contagious Omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) along with its high number of mutations in the spike gene …

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection

K Boonnak, BM Slike, TH Burgess, RM Mason… - Journal of …, 2008 - Am Soc Microbiol
Dengue viruses (DV), composed of four distinct serotypes (DV1 to DV4), cause 50 to 100
million infections annually. Durable homotypic immunity follows infection but may predispose to …

Hark back: passive immunotherapy for influenza and other serious infections

…, SL Hoffman, JH Beigel, TH Burgess - Critical care …, 2010 - journals.lww.com
The world is experiencing a pandemic of swine-origin influenza virus H1N1. A vaccine to
prevent disease is now available, and millions have or will become ill before they can be …

[HTML][HTML] An outbreak of Covid-19 on an aircraft carrier

…, D Houskamp, R Fenequito, TH Burgess… - … England Journal of …, 2020 - Mass Medical Soc
Background An outbreak of coronavirus disease 2019 (Covid-19) occurred on the USS
Theodore Roosevelt, a nuclear-powered aircraft carrier with a crew of 4779 personnel. Methods …

[PDF][PDF] Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

…, DR Tribble, ED Laing, BK Agan, TH Burgess… - Cell host & …, 2022 - cell.com
The rapid emergence of SARS-CoV-2 variants challenges vaccination strategies. Here, we
collected 201 serum samples from persons with a single infection or multiple vaccine …

[HTML][HTML] Infectious etiologies of acute febrile illness among patients seeking health care in south-central Cambodia

…, M Williams, AL Richards, TH Burgess… - The American journal …, 2012 - ncbi.nlm.nih.gov
The agents of human febrile illness can vary by region and country suggesting that diagnosis,
treatment, and control programs need to be based on a methodical evaluation of area-…